• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ca2.2 N型钙通道调节剂CBD3063的R和S对映体可减轻辣椒素诱导的炎性疼痛。

R and S enantiomers of CBD3063, a Ca2.2 N-type calcium channel modulator, alleviate capsaicin-induced inflammatory pain.

作者信息

Loya-López Santiago, Rodríguez-Palma Erick J, Calderón-Rivera Aida, Gomez Kimberly, Perez-Miller Samantha, Khanna Rajesh

机构信息

Department of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, FL, USA.

Center for Advanced Pain Therapeutics and Research (CAPTOR), College of Medicine, University of Florida, Gainesville, FL, USA.

出版信息

Neurobiol Pain. 2025 May 16;18:100185. doi: 10.1016/j.ynpai.2025.100185. eCollection 2025 Jul-Dec.

DOI:10.1016/j.ynpai.2025.100185
PMID:40487899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12145844/
Abstract

N-type voltage-gated calcium channels (Ca2.2) play a pivotal role in pain signaling, rendering them promising targets for pain treatment. However, direct blockers of Ca2.2 have demonstrated limited efficacy due to adverse side effects and inadequate blood-brain barrier penetration. In previous work, we developed CBD3063, a small molecule peptidomimetic that disrupts the Ca2.2-CRMP2 (collapsin response mediator protein 2) interaction, resulting in a reduction of Ca2.2 currents and pain relief without side effects. In this study, we investigated the individual contributions of the (R) and (S) enantiomers of CBD3063 to its pharmacological effects. Whole-cell patch-clamp recordings from mouse dorsal root ganglion (DRG) sensory neurons indicated that the (S) and (R) enantiomers reduced Ca2.2 currents. Furthermore, racemic CBD3063 and the (S) enantiomer exhibited antinociceptive effects in the capsaicin-induced model of inflammatory pain. These findings suggest that the (S) and (R) enantiomers contribute to the therapeutic effects of CBD3063.

摘要

N型电压门控钙通道(Ca2.2)在疼痛信号传导中起关键作用,使其成为有前景的疼痛治疗靶点。然而,由于副作用和血脑屏障穿透不足,Ca2.2的直接阻滞剂疗效有限。在先前的工作中,我们开发了CBD3063,一种小分子肽模拟物,它破坏Ca2.2与CRMP2(塌陷反应介导蛋白2)的相互作用,从而减少Ca2.2电流并缓解疼痛且无副作用。在本研究中,我们研究了CBD3063的(R)和(S)对映体对其药理作用的各自贡献。从小鼠背根神经节(DRG)感觉神经元进行的全细胞膜片钳记录表明,(S)和(R)对映体均降低了Ca2.2电流。此外,外消旋CBD3063和(S)对映体在辣椒素诱导的炎性疼痛模型中表现出抗伤害感受作用。这些发现表明,(S)和(R)对映体均对CBD

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/e7b0072dad54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/f52ce7586d22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/cd97f95bcd01/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/e7b0072dad54/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/f52ce7586d22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/cd97f95bcd01/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b87/12145844/e7b0072dad54/gr3.jpg

相似文献

1
R and S enantiomers of CBD3063, a Ca2.2 N-type calcium channel modulator, alleviate capsaicin-induced inflammatory pain.Ca2.2 N型钙通道调节剂CBD3063的R和S对映体可减轻辣椒素诱导的炎性疼痛。
Neurobiol Pain. 2025 May 16;18:100185. doi: 10.1016/j.ynpai.2025.100185. eCollection 2025 Jul-Dec.
2
A peptidomimetic modulator of the Ca2.2 N-type calcium channel for chronic pain.一种慢性疼痛的 Ca2.2 N 型钙通道的肽模拟调节剂。
Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2305215120. doi: 10.1073/pnas.2305215120. Epub 2023 Nov 16.
3
Uncoupling the CRMP2-Ca2.2 Interaction Reduces Pain-Like Behavior in a Preclinical Joint-Pain Model.解偶联 CRMP2-Ca2.2 相互作用可减少临床前关节痛模型中的疼痛样行为。
J Pain. 2024 Dec;25(12):104664. doi: 10.1016/j.jpain.2024.104664. Epub 2024 Sep 2.
4
Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.靶向 collapsin 反应介导蛋白 2 与 N 型钙通道相互作用以缓解疼痛的肽和拟肽抑制剂
ACS Pharmacol Transl Sci. 2024 Jun 6;7(7):1916-1936. doi: 10.1021/acsptsci.4c00181. eCollection 2024 Jul 12.
5
Uncoupling the CRMP2-Ca2.2 interaction reduces pain-like behavior in a preclinical osteoarthritis model.在临床前骨关节炎模型中,解除CRMP2与Ca2.2的相互作用可减轻疼痛样行为。
bioRxiv. 2024 Jun 6:2024.06.05.596514. doi: 10.1101/2024.06.05.596514.
6
A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.一种膜限定的N-肉豆蔻酰化CRMP2肽适配体可抑制CaV2.2转运,并逆转炎症性疼痛和术后疼痛行为。
Pain. 2015 Jul;156(7):1247-1264. doi: 10.1097/j.pain.0000000000000147.
7
(S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.(S)-拉科酰胺对CRMP2磷酸化的抑制作用通过星座药理学鉴定的不同类型感觉神经元减轻术后疼痛和神经性疼痛行为。
Pain. 2016 Jul;157(7):1448-1463. doi: 10.1097/j.pain.0000000000000555.
8
Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.新型合成钙通道肽抑制递质释放及减轻抗逆转录病毒相关和胫骨神经损伤相关的痛性周围神经病。
J Biol Chem. 2012 Oct 12;287(42):35065-35077. doi: 10.1074/jbc.M112.378695. Epub 2012 Aug 13.
9
N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.N型钙电流(Cav2.2)在从Nf1+/-小鼠分离出的小直径感觉神经元中增强。
Neuroscience. 2014 Jun 13;270:192-202. doi: 10.1016/j.neuroscience.2014.04.021. Epub 2014 Apr 19.
10
Reversal of Peripheral Neuropathic Pain by the Small-Molecule Natural Product Physalin F via Block of CaV2.3 (R-Type) and CaV2.2 (N-Type) Voltage-Gated Calcium Channels.小分子天然产物黄皮酰胺 F 通过阻断 CaV2.3(R 型)和 CaV2.2(N 型)电压门控钙通道逆转周围神经性疼痛。
ACS Chem Neurosci. 2019 Jun 19;10(6):2939-2955. doi: 10.1021/acschemneuro.9b00166. Epub 2019 Apr 18.

本文引用的文献

1
Targeting Na1.7 and Na1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain.使用磷脂酰肌醇激酶磷酸酶5(PIKfyve)抑制剂靶向Nav1.7和Nav1.8以逆转炎性和神经性疼痛。
Neurobiol Pain. 2024 Nov 29;17:100174. doi: 10.1016/j.ynpai.2024.100174. eCollection 2025 Jan-Jun.
2
C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models.C2230是一种优先作用于使用和状态依赖性的CaV2.2通道阻滞剂,可减轻多种疼痛模型中的疼痛行为。
J Clin Invest. 2024 Dec 10;135(4):e177429. doi: 10.1172/JCI177429.
3
Uncoupling the CRMP2-Ca2.2 Interaction Reduces Pain-Like Behavior in a Preclinical Joint-Pain Model.
解偶联 CRMP2-Ca2.2 相互作用可减少临床前关节痛模型中的疼痛样行为。
J Pain. 2024 Dec;25(12):104664. doi: 10.1016/j.jpain.2024.104664. Epub 2024 Sep 2.
4
Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.靶向 collapsin 反应介导蛋白 2 与 N 型钙通道相互作用以缓解疼痛的肽和拟肽抑制剂
ACS Pharmacol Transl Sci. 2024 Jun 6;7(7):1916-1936. doi: 10.1021/acsptsci.4c00181. eCollection 2024 Jul 12.
5
Interleukin-1α links peripheral Ca2.2 channel activation to rapid adaptive increases in heat sensitivity in skin.白细胞介素-1α 将外周钙 2.2 通道激活与皮肤热敏感性的快速适应增加联系起来。
Sci Rep. 2024 Apr 20;14(1):9051. doi: 10.1038/s41598-024-59424-6.
6
A peptidomimetic modulator of the Ca2.2 N-type calcium channel for chronic pain.一种慢性疼痛的 Ca2.2 N 型钙通道的肽模拟调节剂。
Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2305215120. doi: 10.1073/pnas.2305215120. Epub 2023 Nov 16.
7
Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.新型非对映异构体混合物 R-和 S-二甲替林(MP-101)的药理学特征,其在认知、抑郁和神经病理性疼痛的大鼠模型中具有增强的效力。
Cells. 2022 Dec 13;11(24):4027. doi: 10.3390/cells11244027.
8
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.加巴喷丁类药物在新出现的滥用责任方面的药理学
J Clin Pharmacol. 2021 Aug;61 Suppl 2:S89-S99. doi: 10.1002/jcph.1833.
9
Structure of human Ca2.2 channel blocked by the painkiller ziconotide.人类钙通道 2.2 型被痛觉阻断剂 ziconotide 阻断的结构。
Nature. 2021 Aug;596(7870):143-147. doi: 10.1038/s41586-021-03699-6. Epub 2021 Jul 7.
10
Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods.药物药代动力学和毒性中的对映体选择性:药理学相关性及分析方法
Molecules. 2021 May 23;26(11):3113. doi: 10.3390/molecules26113113.